News & Articles

The partnership aims to drive digital health collaborations, including artificial intelligence-enabled applications

Our expert webinar series aims to help you get the most from your drug discovery research

The RECOVERY trial has shown that hydroxychloroquine is not an effective treatment in patients hospitalized with COVID-19

This aims to make use of its collective and accumulated knowledge of graphene to fight the current pandemic

Total antibody test aims to deliver superior clinical performance with 100% sensitivity and 99.8% specificity

Join us on Tuesday, June 9, to explore the qualitative and quantitative characterization of mAb and protein stability, both in vitro and in vivo, by CE-MS and LC-MS

The trial will study the use of ruxolitinib, a JAK inhibitor, to investigate its effect on reducing complications in deteriorating COVID-19 patients

Find out how small data systems can create new possibilities for better, more verifiable science in your lab in this SelectScience webinar

Harnessing the most powerful force in the fight against disease — natural human immunity

The platform aims to help researchers generate a clearer view of the current state of research and gain invaluable insights

Register for this webinar to discover how pancreatic cancer-derived organoids can be used as a predictive tool for personalized medicine

The cPass™ – SARS-CoV-2 Surrogate Virus Neutralization Test (sVNT) Kit aims to detect the presence of neutralizing antibodies in an hour

The company aims to ramp up its production capacity of more than 50 million antibody tests per month

Test will be available at NHS laboratories across the UK, using its ARCHITECT i1000SR and i2000SR and Alinity i laboratory instruments

Interim clinical study data shows ID NOW test performance of 94.7% sensitivity and 98.6% specificity

Driven by the gap in COVID-19 testing, the collaboration aims to create a fully disposable, rapid and handheld test for consumers

Dr. Sylvia Boj discusses the advantages of organoids and how these 3D tissue cultures have enormous potential to revolutionize how we treat patients and predict therapeutic response

Register for this webinar to learn more about how live-cell monitoring can support optimization of advanced cellular models

A qualitative test for the detection of nucleic acid from SARS-CoV-2

The COVID-19 vaccine trial is part of a global development program that will uncover the safety and immunogenicity of four mRNA vaccine candidates.

Test deployed on Quanterix' Simoa platform promises 1,000-fold sensitivity improvement

From AI to artificial lifeforms, we spotlight the latest research and automation solutions innovating life sciences and drug discovery

Instrument was voted for by scientists around the globe as the Best New Life Sciences Product, at the 2020 Scientists’ Choice Awards

Collaboration with WuXi Diagnostics and Mayo Clinic on serology test will complement Thermo Fisher's widely adopted TaqPath COVID-19 molecular diagnostic test